Gennex Laboratories Dissolves Rights Issue Committee

Gennex Laboratories Limited announced the dissolution of its Rights Issue Committee, effective November 14, 2026. The committee was established to manage the company's Rights Issue of equity shares. As the Rights Issue process has been successfully completed, including all necessary formalities and listing approvals, the committee's mandate has been fulfilled. The company has also uploaded this intimation on its website.